Fig. 9
Images of HepG2, HCT116, and MDAmb231 cells treated with cisplatin (12.5 μg/mL) and SC 1 (25 μg/mL) after 48 h according to the viability percentage using inverted microscope 20× objective lenses
Fig. 9 | BMC Chemistry
Images of HepG2, HCT116, and MDAmb231 cells treated with cisplatin (12.5 μg/mL) and SC 1 (25 μg/mL) after 48 h according to the viability percentage using inverted microscope 20× objective lenses